Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues. Clementia Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
Frequently Asked Questions
What is Market Cap of Clementia Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Clementia Pharmaceuticals Inc market cap is N/A.
What is the 52-week high for Clementia Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clementia Pharmaceuticals Inc 52 week high is N/A as of October 10, 2025.
What is the 52-week low for Clementia Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clementia Pharmaceuticals Inc 52 week low is N/A as of October 10, 2025.
What was Clementia Pharmaceuticals Inc stock price yesterday?
Clementia Pharmaceuticals Inc stock price yesterday was $26.35.
What is the PE ratio of Clementia Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Clementia Pharmaceuticals Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Clementia Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Clementia Pharmaceuticals Inc P/B ratio is None.
What is Clementia Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Clementia Pharmaceuticals Inc's EBITDA is N/A.
What is the 50-day moving average of Clementia Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Clementia Pharmaceuticals Inc 50-day moving average is N/A.
How many employess does Clementia Pharmaceuticals Inc has?
